A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma

Authors: Weijia Cai, Mai Q. Nguyen, Nicole A. Wilski, Timothy J. Purwin, Mégane Vernon, Manoela Tiago, Andrew E. Aplin

Published: 2022-07-18

DOI: 10.1158/0008-5472.can-21-3217

Source: Full article